About this document
Sni 14 225 by Adhar Amritt is a document available to read on EtoBox.
The article reviews the molecular profiling of diffuse gliomas, emphasizing their classification based on mutational markers alongside traditional histology. It highlights the 2021 WHO classification, which integrates molecular aspects crucial for determining patient outcomes and potential targeted therapies. Key molecular markers identified include IDH mutations, 1p/19q codeletion, and TP53 mutations, underscoring the importance of molecular profiling in clinical decision-making for glioma treatment.
- Author
- Adhar Amritt
- Language
- EN